Industry: Machinery & Equipment
Published Date: 2025-08-05
Pages: 182 Pages
Report ld: 4866107
Request Sample
Customized Report
The global Fully Automated Nucleic Acid Purification System market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
From a downstream perspective, Clinical Diagnostics accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).
Fully Automated Nucleic Acid Purification System leading manufacturers including Daan Gene, Promega Corporation, Analytik Jena GmbH+Co, BIOBASE Group, Aurora, Bioneer Corporation, TransGen Biotech Co., Ltd, QIAGEN, Hybribio, Sansure Biotech Inc, etc., dominate supply; the top five capture approximately % of global revenue, with Daan Gene leading 2024 sales at US$ million.
Regional Outlook:
North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).
Asia‑Pacific will expand from US$ million to US$ million (CAGR %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).
Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).
Report Includes:
This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Fully Automated Nucleic Acid Purification System market, seamlessly integrating production capacity and sales performance across the value chain. It analyzes historical production, revenue, and sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—capacity, sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
MARKET SEGMENTATION
CHAPTER OUTLINE
Chapter 1: Defines the Fully Automated Nucleic Acid Purification System study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Maps global production capacity, utilization, and market share (2020–2031), identifies efficient hubs, reveals regulatory/trade policy impacts and bottlenecks.
Chapter 4: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 5: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 6: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 7: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 8: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 9: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 10: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 11: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 12: Profiles manufacturers in depth—details product specs, capacity, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 13: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint and technology, cost drivers, plus downstream channels and distributor roles.
Chapter 14: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
WHY THIS REPORT
Beyond standard market data, this analysis provides a clear profitability roadmap, empowering you to:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 7–11) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 13) and customers (Chapter 6) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 4 and 12).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 13 and 14).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.
QYRESEARCH'S STRENGTHS
Unlike generic global market reports, this study combines macro-level industry trends with hyper-local operational intelligence, empowering data-driven decisions across the Compound Chocolate value chain, addressing:
We identify regional market threats and growth prospects to guide your overseas layout.
We adjust product portfolios in line with local consumption habits.
We unpack rivals’ operation strategies for scattered and highly concentrated industries.
We cover competition landscape, full supply chain and quantified market size data, and deliver tailor-made customized surveys to meet your unique business demands.
We own self-owned massive exclusive databases, backed by 19 years of global market research experience across thousands of sectors.
Our team operates 24 hours a day, 365 days a year, enabling ultra-fast report turnaround to respond to your research needs efficiently.
We integrate regional risk assessment, localized product optimization and competitor analysis to deliver actionable market strategies.
All data is cross-verified from multiple industry sources to deliver thorough, precise analysis that supports reliable corporate strategic decisions.
We provide responsive, dedicated after-sales support to resolve all follow-up inquiries about reports, data and industry interpretation.
TABLE OF CONTENTS
1 Study Coverage
1.1 Introduction to Fully Automated Nucleic Acid Purification System: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Fully Automated Nucleic Acid Purification System Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 High Throughput Systems
1.2.3 Medium Throughput Systems
1.2.4 Low Throughput Systems
1.3 Market Segmentation by Application
1.3.1 Global Fully Automated Nucleic Acid Purification System Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Clinical Diagnostics
1.3.3 Pharmaceutical Research
1.3.4 Forensic Science
1.3.5 Agricultural and Environmental Biotechnology
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Fully Automated Nucleic Acid Purification System Revenue Estimates and Forecasts 2020-2031
2.2 Global Fully Automated Nucleic Acid Purification System Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Fully Automated Nucleic Acid Purification System Sales Estimates and Forecasts 2020-2031
2.4 Global Fully Automated Nucleic Acid Purification System Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Global Production Analysis
3.1 Global Fully Automated Nucleic Acid Purification System Production Capacity and Utilization Rates (2020–2031)
3.2 Regional Production: Comparative Analysis (2020 VS 2024 VS 2031)
3.3 Regional Production Dynamics
3.3.1 Historic Production by Region (2020-2025)
3.3.2 Forecasted Production by Region (2026-2031)
3.3.3 Production Market Share by Region (2020-2031)
3.3.4 Regulatory and Trade Policy Impact on Production
3.3.5 Production Capacity Enablers and Constraints
3.4 Key Regional Production Hubs
3.4.1 North America
3.4.2 Europe
3.4.3 China
3.4.4 Japan
4 Competition by Manufacturers
4.1 Global Fully Automated Nucleic Acid Purification System Sales by Manufacturers
4.1.1 Global Sales Volume by Manufacturers (2020-2025)
4.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
4.2 Global Fully Automated Nucleic Acid Purification System Manufacturer Revenue Rankings and Tiers
4.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
4.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
4.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
4.3 Manufacturer Profitability Profiles and Pricing Strategies
4.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
4.3.2 Manufacturer-Level Price Trends (2020-2025)
4.4 Key Manufacturers Manufacturing Base and Headquarters
4.5 Main Product Type Market Size by Manufacturers
4.5.1 High Throughput Systems Market Size by Manufacturers
4.5.2 Medium Throughput Systems Market Size by Manufacturers
4.5.3 Low Throughput Systems Market Size by Manufacturers
4.6 Global Fully Automated Nucleic Acid Purification System Market Concentration and Dynamics
4.6.1 Global Market Concentration (CR5 and HHI)
4.6.2 Entrant/Exit Impact Analysis
4.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
5 Global Product Segmentation Analysis
5.1 Global Fully Automated Nucleic Acid Purification System Sales Performance by Type
5.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
5.1.2 Global Sales Market Share by Type (2020-2031)
5.2 Global Fully Automated Nucleic Acid Purification System Revenue Trends by Type
5.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
5.2.2 Global Revenue Market Share by Type (2020-2031)
5.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
5.4 Product Technology Differentiation
5.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
5.5.1 High-Growth Niches and Adoption Drivers
5.5.2 Profitability Hotspots and Cost Drivers
5.5.3 Substitution Threats
6 Global Downstream Application Analysis
6.1 Global Fully Automated Nucleic Acid Purification System Sales by Application
6.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
6.1.2 Global Sales Market Share by Application (2020-2031)
6.1.3 High-Growth Application Identification
6.1.4 Emerging Application Case Studies
6.2 Global Fully Automated Nucleic Acid Purification System Revenue by Application
6.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
6.2.2 Revenue Market Share by Application (2020-2031)
6.3 Global Pricing Dynamics by Application (2020-2031)
6.4 Downstream Customer Analysis
6.4.1 Top Customers by Region
6.4.2 Top Customers by Application
7 North America
7.1 North America Sales Volume and Revenue (2020-2031)
7.2 North America Key Manufacturers Sales Revenue in 2024
7.3 North America Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)
7.4 North America Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)
7.5 North America Growth Accelerators and Market Barriers
7.6 North America Fully Automated Nucleic Acid Purification System Market Size by Country
7.6.1 North America Revenue by Country
7.6.2 North America Sales Trends by Country
7.6.3 US
7.6.4 Canada
7.6.5 Mexico
8 Europe
8.1 Europe Sales Volume and Revenue (2020-2031)
8.2 Europe Key Manufacturers Sales Revenue in 2024
8.3 Europe Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)
8.4 Europe Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)
8.5 Europe Growth Accelerators and Market Barriers
8.6 Europe Fully Automated Nucleic Acid Purification System Market Size by Country
8.6.1 Europe Revenue by Country
8.6.2 Europe Sales Trends by Country
8.6.3 Germany
8.6.4 France
8.6.5 U.K.
8.6.6 Italy
8.6.7 Russia
9 Asia-Pacific
9.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
9.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
9.3 Asia-Pacific Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)
9.4 Asia-Pacific Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)
9.5 Asia-Pacific Fully Automated Nucleic Acid Purification System Market Size by Region
9.5.1 Asia-Pacific Revenue by Region
9.5.2 Asia-Pacific Sales Trends by Region
9.6 Asia-Pacific Growth Accelerators and Market Barriers
9.7 Southeast Asia
9.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
9.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand
9.8 China
9.9 Japan
9.10 South Korea
9.11 China Taiwan
9.12 India
10 Central and South America
10.1 Central and South America Sales Volume and Revenue (2020-2031)
10.2 Central and South America Key Manufacturers Sales Revenue in 2024
10.3 Central and South America Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)
10.4 Central and South America Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)
10.5 Central and South America Investment Opportunities and Key Challenges
10.6 Central and South America Fully Automated Nucleic Acid Purification System Market Size by Country
10.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 Brazil
10.6.3 Argentina
11 Middle East and Africa
11.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
11.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
11.3 Middle East and Africa Fully Automated Nucleic Acid Purification System Sales and Revenue by Type (2020-2031)
11.4 Middle East and Africa Fully Automated Nucleic Acid Purification System Sales and Revenue by Application (2020-2031)
11.5 Middle East and Africa Investment Opportunities and Key Challenges
11.6 Middle East and Africa Fully Automated Nucleic Acid Purification System Market Size by Country
11.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
11.6.2 GCC Countries
11.6.3 Turkey
11.6.4 Egypt
11.6.5 South Africa
12 Corporate Profile
12.1 Daan Gene
12.1.1 Daan Gene Corporation Information
12.1.2 Daan Gene Business Overview
12.1.3 Daan Gene Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.1.4 Daan Gene Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.1.5 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Product in 2024
12.1.6 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Application in 2024
12.1.7 Daan Gene Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024
12.1.8 Daan Gene Fully Automated Nucleic Acid Purification System SWOT Analysis
12.1.9 Daan Gene Recent Developments
12.2 Promega Corporation
12.2.1 Promega Corporation Corporation Information
12.2.2 Promega Corporation Business Overview
12.2.3 Promega Corporation Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.2.4 Promega Corporation Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.2.5 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Product in 2024
12.2.6 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Application in 2024
12.2.7 Promega Corporation Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024
12.2.8 Promega Corporation Fully Automated Nucleic Acid Purification System SWOT Analysis
12.2.9 Promega Corporation Recent Developments
12.3 Analytik Jena GmbH+Co
12.3.1 Analytik Jena GmbH+Co Corporation Information
12.3.2 Analytik Jena GmbH+Co Business Overview
12.3.3 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.3.4 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.3.5 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Product in 2024
12.3.6 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Application in 2024
12.3.7 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024
12.3.8 Analytik Jena GmbH+Co Fully Automated Nucleic Acid Purification System SWOT Analysis
12.3.9 Analytik Jena GmbH+Co Recent Developments
12.4 BIOBASE Group
12.4.1 BIOBASE Group Corporation Information
12.4.2 BIOBASE Group Business Overview
12.4.3 BIOBASE Group Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.4.4 BIOBASE Group Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.4.5 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Product in 2024
12.4.6 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Application in 2024
12.4.7 BIOBASE Group Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024
12.4.8 BIOBASE Group Fully Automated Nucleic Acid Purification System SWOT Analysis
12.4.9 BIOBASE Group Recent Developments
12.5 Aurora
12.5.1 Aurora Corporation Information
12.5.2 Aurora Business Overview
12.5.3 Aurora Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.5.4 Aurora Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.5.5 Aurora Fully Automated Nucleic Acid Purification System Sales by Product in 2024
12.5.6 Aurora Fully Automated Nucleic Acid Purification System Sales by Application in 2024
12.5.7 Aurora Fully Automated Nucleic Acid Purification System Sales by Geographic Area in 2024
12.5.8 Aurora Fully Automated Nucleic Acid Purification System SWOT Analysis
12.5.9 Aurora Recent Developments
12.6 Bioneer Corporation
12.6.1 Bioneer Corporation Corporation Information
12.6.2 Bioneer Corporation Business Overview
12.6.3 Bioneer Corporation Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.6.4 Bioneer Corporation Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.6.5 Bioneer Corporation Recent Developments
12.7 TransGen Biotech Co., Ltd
12.7.1 TransGen Biotech Co., Ltd Corporation Information
12.7.2 TransGen Biotech Co., Ltd Business Overview
12.7.3 TransGen Biotech Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.7.4 TransGen Biotech Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.7.5 TransGen Biotech Co., Ltd Recent Developments
12.8 QIAGEN
12.8.1 QIAGEN Corporation Information
12.8.2 QIAGEN Business Overview
12.8.3 QIAGEN Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.8.4 QIAGEN Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.8.5 QIAGEN Recent Developments
12.9 Hybribio
12.9.1 Hybribio Corporation Information
12.9.2 Hybribio Business Overview
12.9.3 Hybribio Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.9.4 Hybribio Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.9.5 Hybribio Recent Developments
12.10 Sansure Biotech Inc
12.10.1 Sansure Biotech Inc Corporation Information
12.10.2 Sansure Biotech Inc Business Overview
12.10.3 Sansure Biotech Inc Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.10.4 Sansure Biotech Inc Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.10.5 Sansure Biotech Inc Recent Developments
12.11 Zeesan Biotech
12.11.1 Zeesan Biotech Corporation Information
12.11.2 Zeesan Biotech Business Overview
12.11.3 Zeesan Biotech Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.11.4 Zeesan Biotech Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.11.5 Zeesan Biotech Recent Developments
12.12 Lepu Medical Technology(Beijing)Co.,Ltd
12.12.1 Lepu Medical Technology(Beijing)Co.,Ltd Corporation Information
12.12.2 Lepu Medical Technology(Beijing)Co.,Ltd Business Overview
12.12.3 Lepu Medical Technology(Beijing)Co.,Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.12.4 Lepu Medical Technology(Beijing)Co.,Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.12.5 Lepu Medical Technology(Beijing)Co.,Ltd Recent Developments
12.13 Thermofisher Scientific
12.13.1 Thermofisher Scientific Corporation Information
12.13.2 Thermofisher Scientific Business Overview
12.13.3 Thermofisher Scientific Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.13.4 Thermofisher Scientific Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.13.5 Thermofisher Scientific Recent Developments
12.14 MGI Tech Co., Ltd
12.14.1 MGI Tech Co., Ltd Corporation Information
12.14.2 MGI Tech Co., Ltd Business Overview
12.14.3 MGI Tech Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.14.4 MGI Tech Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.14.5 MGI Tech Co., Ltd Recent Developments
12.15 Xi'an Tianlong Science and Technology Co., Ltd
12.15.1 Xi'an Tianlong Science and Technology Co., Ltd Corporation Information
12.15.2 Xi'an Tianlong Science and Technology Co., Ltd Business Overview
12.15.3 Xi'an Tianlong Science and Technology Co., Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.15.4 Xi'an Tianlong Science and Technology Co., Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.15.5 Xi'an Tianlong Science and Technology Co., Ltd Recent Developments
12.16 TIANGEN BIOTECH (BEIJING) CO.,LTD
12.16.1 TIANGEN BIOTECH (BEIJING) CO.,LTD Corporation Information
12.16.2 TIANGEN BIOTECH (BEIJING) CO.,LTD Business Overview
12.16.3 TIANGEN BIOTECH (BEIJING) CO.,LTD Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.16.4 TIANGEN BIOTECH (BEIJING) CO.,LTD Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.16.5 TIANGEN BIOTECH (BEIJING) CO.,LTD Recent Developments
12.17 novogene
12.17.1 novogene Corporation Information
12.17.2 novogene Business Overview
12.17.3 novogene Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.17.4 novogene Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.17.5 novogene Recent Developments
12.18 CLONIT srl
12.18.1 CLONIT srl Corporation Information
12.18.2 CLONIT srl Business Overview
12.18.3 CLONIT srl Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.18.4 CLONIT srl Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.18.5 CLONIT srl Recent Developments
12.19 F. Hoffmann-La Roche
12.19.1 F. Hoffmann-La Roche Corporation Information
12.19.2 F. Hoffmann-La Roche Business Overview
12.19.3 F. Hoffmann-La Roche Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.19.4 F. Hoffmann-La Roche Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.19.5 F. Hoffmann-La Roche Recent Developments
12.20 Esco Micro Pte. Ltd
12.20.1 Esco Micro Pte. Ltd Corporation Information
12.20.2 Esco Micro Pte. Ltd Business Overview
12.20.3 Esco Micro Pte. Ltd Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.20.4 Esco Micro Pte. Ltd Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.20.5 Esco Micro Pte. Ltd Recent Developments
12.21 zinexts
12.21.1 zinexts Corporation Information
12.21.2 zinexts Business Overview
12.21.3 zinexts Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.21.4 zinexts Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.21.5 zinexts Recent Developments
12.22 GeneProof
12.22.1 GeneProof Corporation Information
12.22.2 GeneProof Business Overview
12.22.3 GeneProof Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.22.4 GeneProof Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.22.5 GeneProof Recent Developments
12.23 Magen Biotechnology
12.23.1 Magen Biotechnology Corporation Information
12.23.2 Magen Biotechnology Business Overview
12.23.3 Magen Biotechnology Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.23.4 Magen Biotechnology Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.23.5 Magen Biotechnology Recent Developments
12.24 ADS Biotec Inc
12.24.1 ADS Biotec Inc Corporation Information
12.24.2 ADS Biotec Inc Business Overview
12.24.3 ADS Biotec Inc Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.24.4 ADS Biotec Inc Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.24.5 ADS Biotec Inc Recent Developments
12.25 Wuxi Techstar Technology Co
12.25.1 Wuxi Techstar Technology Co Corporation Information
12.25.2 Wuxi Techstar Technology Co Business Overview
12.25.3 Wuxi Techstar Technology Co Fully Automated Nucleic Acid Purification System Product Models, Descriptions and Specifications
12.25.4 Wuxi Techstar Technology Co Fully Automated Nucleic Acid Purification System Capacity, Sales, Price, Revenue and Gross Margin (2020-2025)
12.25.5 Wuxi Techstar Technology Co Recent Developments
13 Value Chain and Supply-Chain Analysis
13.1 Fully Automated Nucleic Acid Purification System Industry Chain
13.2 Fully Automated Nucleic Acid Purification System Upstream Materials Analysis
13.2.1 Raw Materials
13.2.2 Key Suppliers Market Share & Risk Assessment
13.3 Fully Automated Nucleic Acid Purification System Integrated Production Analysis
13.3.1 Manufacturing Footprint Analysis
13.3.2 Production Technology Overview
13.3.3 Regional Cost Drivers
13.4 Fully Automated Nucleic Acid Purification System Sales Channels and Distribution Networks
13.4.1 Sales Channels
13.4.2 Distributors
14 Fully Automated Nucleic Acid Purification System Market Dynamics
14.1 Industry Trends and Evolution
14.2 Market Growth Drivers and Emerging Opportunities
14.3 Market Challenges, Risks, and Restraints
15 Key Findings in the Global Fully Automated Nucleic Acid Purification System Study
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.1.1 Research Programs/Design
16.1.1.2 Market Size Estimation
16.1.1.3 Market Breakdown and Data Triangulation
16.1.2 Data Source
16.1.2.1 Secondary Sources
16.1.2.2 Primary Sources
16.2 Author Details
TABLE OF FIGURES
List of Tables
List of Figures
KEY QUESTIONS ADDRESSED BY THE REPORT
Related Reports
The global Fully Automated Nucleic Acid Purification System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published Date: 2026-03-26
Pages: 196
USD 4900.00
(Single User License)
The global Fully Automated Nucleic Acid Purification System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published Date: 2026-03-26
Pages: 117
USD 4250.00
(Single User License)
The global market for Fully Automated Nucleic Acid Purification System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 169
USD 3950.00
(Single User License)
The global Fully Automated Nucleic Acid Purification System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published Date: 2026-01-09
Pages: 164
USD 2900.00
(Single User License)
The global market for Fully Automated Nucleic Acid Purification System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-09-13
Pages: 157
USD 3950.00
(Single User License)
The global Fully Automated Nucleic Acid Purification System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published Date: 2025-03-10
Pages: 117
USD 4250.00
(Single User License)
The global market for Fully Automated Nucleic Acid Purification System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published Date: 2025-03-10
Pages: 122
USD 2900.00
(Single User License)
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published Date: 2024-08-24
Pages: 162
USD 4350.00
(Single User License)
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published Date: 2024-08-24
Pages: 192
USD 4900.00
(Single User License)
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published Date: 2024-08-24
Pages: 122
USD 2900.00
(Single User License)
The global Fully Automated Nucleic Acid Purification System market is projected to grow from US$ million in 2025 to US$ million by 2032, at a CAGR of %(2026-2032), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.
Published: 2026-03-26
Pages: 196
The global Fully Automated Nucleic Acid Purification System market size was US$ million in 2025 and is forecast to reach a readjusted size of US$ million by 2032 with a CAGR of %during the forecast period 2026-2032.
Published: 2026-03-26
Pages: 117
The global market for Fully Automated Nucleic Acid Purification System was estimated to be worth US$ million in 2025 and is projected to reach US$ million, growing at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 169
The global Fully Automated Nucleic Acid Purification System market was valued at US$ million in 2025 and is anticipated to reach US$ million by 2032, at a CAGR of %from 2026 to 2032.
Published: 2026-01-09
Pages: 164
The global market for Fully Automated Nucleic Acid Purification System was estimated to be worth US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-09-13
Pages: 157
The global Fully Automated Nucleic Acid Purification System market size was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2031 with a CAGR of %during the forecast period 2025-2031.
Published: 2025-03-10
Pages: 117
The global market for Fully Automated Nucleic Acid Purification System was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Published: 2025-03-10
Pages: 122
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published: 2024-08-24
Pages: 162
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published: 2024-08-24
Pages: 192
A Fully Automated Nucleic Acid Purification System is a laboratory instrument designed to streamline the process of extracting nucleic acids, such as DNA or RNA, from various biological samples (e.g., blood, tissues, cells). These systems automate multiple steps in the purification process, reducing manual labor, minimizing the risk of contamination, and improving reproducibility and throughput. They are widely used in molecular biology, clinical diagnostics, and research settings.
Published: 2024-08-24
Pages: 122
REPORT COVERAGE
DESCRIPTION
OVERVIEW
MARKET SEGMENTATION
CHAPTER OUTLINE
WHY THIS REPORT
QYRESEARCH'S STRENGTHS
TABLE OF CONTENTS
TABLE OF FIGURES
RLEATED REPORTS
INTEREST IN THIS REPORT?
Get A Free Sample
Request For Quotation
OR
NEED A CUSTOMIZED REPORT?
Customized Report
Request Sample
Pre-Order Enquiry
Add to Cart
Buy Now